Navigation Links
The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
Date:1/31/2008

WORCESTER, Massachusetts, February 1 /PRNewswire/ --

- ENDORSE Global Findings Highlight the Need to Urgently Implement Hospital-Wide Strategies to Optimize VTE Management: Systematically Assess Patient Risk for VTE and Provide Appropriate Prophylaxis to Prevent VTE

ENDORSE multinational study (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) published today in the LANCET(1) demonstrates the high prevalence of patients at risk for VTE (according to the ACCP guidelines) in the world: 52% of hospitalized patients surveyed were at risk for VTE, corresponding to 64% of surgical patients and 42% of medical patients.

ENDORSE demonstrates as well, that recommended prophylaxis is only prescribed to 50% of at-risk patients throughout the world, corresponding to 59% of surgical and 40% of medical patients.

With more than 60,000 patients studied in more than 32 countries encompassing 6 continents the scope of ENDORSE is unprecedented. With a wide range of racial, social, economic and health care environment, ENDORSE gives a unique global and local picture about the extent of the hospitalized patient population at risk for VTE and how these patients are managed.

Doctor Fred Anderson, Director of the Center for Outcomes Research at the University of Massachusetts Medical School who conducted the study commented "ENDORSE shows that a substantial proportion of hospitalized patients are at risk for VTE in each of 32 participating countries. Despite these objective data that VTE risk is important on a global scale, the use of recommended prophylaxis is sub-optimal. This is a complex problem, which will require multiple solutions, including local and national programs of education, guideline development, increased reimbursement for prophylaxis, and addition of VTE prevention to the health-care agenda in every country."

VTE is a major public health issu
'/>"/>

SOURCE University of Massachusetts Medical School
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. The Lancet Publishes Vasogens ACCLAIM Results
2. Vasogens Research Published in European Journal of Neuroscience
3. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
4. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
5. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
6. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
7. Researchers outline structure of largest nonvirus particle ever crystallized
8. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
9. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
10. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
11. Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... Barbara A. Myers, CAE, to the newly created ... her new role, Myers will be responsible for ... and production strategies, advancing the Society’s Member-led and ... and continuing to refine organizational, membership and product ...
(Date:5/16/2013)... 16, 2013 Cambridge Healthtech Institute will ... 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, ... a close-up look at the current strategies and innovations ... quality. Leaders in the field will reveal how ... biopharmaceuticals with greater specificity and efficiency. , “In this ...
(Date:5/16/2013)... -- Scientists at the Center for Learning and Memory, ... California -based biopharmaceutical company Magceutics, Inc. ... reversing memory decline in mice with Alzheimer,s Disease. By ... in advanced stage AD mice. The study is the ... for advanced stage AD mice, and is also the ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ... MediPoint: Diagnostic Cardiac Biomarkers for ... and Market Forecasts ... Cardiac Biomarkers for Acute Coronary Syndromes ...
Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
... the Draper Prize, Draper Laboratory, in conjunction with the National Academy ... adults to learn about the impact engineers have had on our ... who have been awarded "Engineering,s Nobel" since 1989. , ... ...
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) ... the position of Vice President, Chief Financial Officer & ... been terminated as Savient,s Chief Financial Officer, effective immediately. ... As our current Vice President of Corporate Finance and ...
... VOLC ), a leader in the development, manufacturing ... coronary and peripheral artery,disease, said today that it will ... Stock Conference on Wednesday, February 18. , ... chief executive,officer, will begin at 9:30 a.m., Pacific Standard ...
Cached Biology Technology:New Educational Website Celebrates the Accomplishments of Engineers 2Savient Announces Appointment of David Gionco as Chief Financial Officer 2Savient Announces Appointment of David Gionco as Chief Financial Officer 3Savient Announces Appointment of David Gionco as Chief Financial Officer 4Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast 2
(Date:5/16/2013)... at MIT may someday eliminate the need for ... their blood-sugar levels and inject themselves with insulin. ... levels in the body and respond by secreting ... function of pancreatic islet cells, which are destroyed ... type of system could ensure that blood-sugar levels ...
(Date:5/16/2013)... Philadelphia, PA, May 16, 2013 The relationship ... intelligence (IQ) has not been clear. Schizophrenia is ... functional disability. There are clues that reduced IQ ... schizophrenia. For example, reduced cognitive ability may precede ... may be present in healthy relatives of people ...
(Date:5/16/2013)... , May 16, 2013 Integrated ... combination with a custom thin film transistor camera ... forensic quality roll image in the smallest and ... Sherlock, an Appendix F Mobile ID FAP 45, ... 95% reduction in size and weight when compared ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3Genetic risk for schizophrenia is connected to reduced IQ 2
... Fox Chase Cancer Center scientists led by immunologist Dietmar ... keeps a mouse strain from developing white blood cells, ... Kappes and his colleagues appears in the Feb. 24 ... mice with this naturally occurring defect in Fox Chase's ...
... acetyl CoA carboxylase 2,or ACC2, appears to turn the ... in part why the animals can eat more and ... Medicine,researchers.,The report that appears online today in the Proceedings ... cells in these mice bred to lack ACC2," said ...
... of the oceans can stimulate the growth of diatoms and ... plants continue to grow. They begin to starve in the ... still is in short supply. Why this happens is unclear, ... kind of chemical warfare in the marine ecosystem, according to ...
Cached Biology News:Fox Chase Cancer Center scientists identify immune-system mutation 2Lack of enzyme turns fat cells into fat burners 2Growth in the sea comes down to a struggle for iron 2Growth in the sea comes down to a struggle for iron 3Growth in the sea comes down to a struggle for iron 4Growth in the sea comes down to a struggle for iron 5
Mouse monoclonal antibody raised against a partial recombinant ALAS2. NCBI Entrez Gene ID = ALAS2...
96-well format (For processing samples on microplate-size MALDI target plates such as those from Bruker, Shimadzu, Thermo, and PerkinElmer) Packaging: 2 / pack...
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
...
Biology Products: